'I donated mum's body to Alzheimer's research what happened next was horrifying'
Her son said 'she was strapped in a chair, and a detonation took place underneath her'
One Arizona man thought he was donating his mother's body to science after her harrowing descent in Alzheimer's - only to discover he had been sent her cremated arm before the rest of her body was strapped to a chair and blown up.
Jim Stauffer cared for his mother Doris throughout her illness before she died at 74 in 2013. He decided to donate her brain to science hoping to contribute to a cure for Alzheimer's disease. The family contacted Biological Resource Center, a local company that brokered the donation of human bodies for research. Within the hour, BRC dispatched a driver to collect Doris.
Jim signed a form authorising medical research on his mother's body. Ten days later, Jim received his mother's cremated remains - but it turns out her ashes were made up of a singular arm sawn off from her body. The rest of her corpse had met a violent fate.
Doris' brain never was used for Alzheimer's research. Instead, her body became part of an Army experiment to measure damage caused by roadside bombs, the Irish Star reports.
Internal BRC and military records show that at least 20 other bodies were also used in the blast experiments without permission of the donors or their relatives, a violation of U.S. Army policy. Jim had also ticked a box specifically banning any kind of experiments on Doris. BRC sold donated bodies like Stauffer's for $5,893 each.
Jim said: "She was strapped in a chair, and a detonation took place underneath her to get an idea of what the human body goes through when a vehicle is hit by an IED. There was wording on this paperwork about performing tests that may involve explosions, and we said, 'No'."
Army officials involved in the project said they never received the consent forms that donors or their families had signed. Rather, the officials said they relied on assurances from BRC that families had agreed to let the bodies be used in such experiments.
BRC, which sold more than 20,000 parts from some 5,000 human bodies over a decade, is no longer in business. Its former owner, Stephen Gore, pleaded guilty to fraud in 2022.
In a statement to Reuters, Gore said that he always tried to honor the wishes of donors and sent consent forms when researchers requested them. Jim said of Gore "He didn't care about the families, he didn't care about the people."
Jim learned of the fate of his mother's body from a Reuters reporter and "curled his lip in anger and clutched his wife Lisa's arm. "We did right," Lisa reassured him. "They just did not honor our wishes."
No federal law regulates body brokers like BRC, and no U.S. government agency monitors what happens to cadavers pledged for use in medical education and research.
"It is not illegal to sell a whole body or the parts of a body for research or education," said University of Iowa law professor Sheldon F. Kurtz, who helped modify the Uniform Anatomical Gift Act, which has been adopted by 46 states. Although the act was updated in 2006, Kurtz said, "the issue of whole bodies or body parts for research or education never came up during our discussions."
Since then, the body trade has become big business. Only one state, New York, keeps detailed records on the industry.
According to the most recent data available, companies that did business in New York shipped at least 100,000 body parts across the country from 2011 to 2014. Reuters obtained the data, which have never been made public, from the state's health department.
"I feel foolish," said Jim. "I'm not a trusting person, but, you have no idea this is going on." Military officials said they took BRC's word that permission had been given. Records show at least 20 more bodies were blown up without consent.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
5 hours ago
- Reuters
Magnitude 6 earthquake strikes off coast of Hokkaido, Japan, GFZ says
June 21 (Reuters) - A Magnitude 6 earthquake struck off coast of Hokkaido, Japan on Sunday, the German Research Centre for Geosciences (GFZ) said. The quake was at a depth of 10 km (6.21 miles), GFZ said.
Scottish Sun
18 hours ago
- Scottish Sun
Are YOU eligible for free fat jabs on the NHS? As GPs start dishing out Mounjaro – all you need to know
Our round-up also reveals what you need to do if your GP denies you a fat jab prescription and advice if you're intending on buying them privately NATIONAL JAB SERVICE Are YOU eligible for free fat jabs on the NHS? As GPs start dishing out Mounjaro – all you need to know THEY are arguably the biggest medical breakthrough of recent times. And from Monday, so-called 'fat jabs' will be made available to many more Brits on the NHS. Advertisement 5 From Monday, GPs will begin prescribing the weight-loss jab Mounjaro in the first anti-obesity rollout of its kind Credit: Getty 5 Health chiefs hope the Mounjaro rollout will turn the tide on England's obesity crisis Credit: Getty In what marks the dawn of a new era, GPs will begin prescribing the weight-loss jab Mounjaro in the first anti-obesity rollout of its kind. More than three million people are thought to be eligible for tirzepatide - the active drug in Mounjaro - the strongest jab on the market. Health chiefs hope it will turn the tide on England's obesity crisis which has seen rates double since the 1990s. Advertisement Injections including Ozempic and Wegovy have previously only been available for type 2 diabetes or through specialist slimming clinics. Family doctors will now be encouraged to prescribe them in a bid to get more people on the meds. Experts hope widespread use will slash work sick days and boost the economy, while reducing rates of cancer, heart disease and dementia. But demand for the drugs is already huge and NHS clinics cannot dish them out fast enough. Here is everything you need to know as the rollout begins: Advertisement What is Mounjaro and what has it been used for so far? 5 Studies found Mounjaro caused 20 per cent weight loss over 18 months Credit: Reuters FOR anyone who has missed the frenzy, Mounjaro, aka tirzepatide, is the newest weight loss injection used on the NHS. It has been around since 2022 and triggers fullness hormones in the gut to prevent hunger and over-eating. This works the same as older jabs Wegovy and Ozempic, all known as GLP-1 agonists, but a recent trial showed it is more effective. A head-to-head study in the New England Journal of Medicine found Mounjaro caused 20 per cent weight loss over 18 months, while semaglutide – the active ingredient in Wegovy and Ozempic – led to 14 per cent. Advertisement All the jabs were originally invented to treat type 2 diabetes but trials found they could also cause major weight loss. Pharma firms have cashed in on the discovery and UK prescriptions have skyrocketed. NHS prescriptions of Mounjaro in England surged from just 3,300 in 2023 to 1.1million last year, and more than a million people are estimated to be buying it online. Weight Loss Jabs - Pros vs Cons Who will be eligible in the new rollout? THE new rollout starting on Monday will allow GPs to prescribe tirzepatide for weight loss, starting with those patients whose weight places them at greatest health risk. Top of the list will be those with a body mass index (BMI) of 40 or higher and four weight-related health conditions. Advertisement A BMI of 40 is roughly equal to weighing 16st (102kg) for an average height 5'3' woman, or 19st 6lbs (123kg) for an average 5'9' man. Weight-related conditions include high cholesterol, high blood pressure, prediabetes, type 2 diabetes, obstructive sleep apnoea and heart disease. Patients will likely be expected to have tried diet and exercise first before being offered a jab. Many are likely to miss out, as some 13.5million adults in England are obese but only 3.4million are estimated to be eligible in the rollout. How will the rollout be run and what is new? 5 Wes Streeting wants a more widespread use of the drugs but patients must also receive check-ups Credit: Getty Advertisement WHAT'S new is that the rollout will be the first run by NHS primary care, led by GP surgeries. In theory this should make life easier for patients – but GPs will not be able to meet the huge demand. NHS bosses have admitted it will take a staggering 12 years to treat everyone who is eligible. Just 220,000 extra people are likely to get Mounjaro by 2028. Private prescriptions, costing about £100-£150 per month, already vastly outnumber that and are rising. Advertisement Health Secretary Wes Streeting wants a faster rollout and more widespread use of the drugs but patients must also receive regular check-ups and lifestyle help. Officials are investigating whether they can dish them out through pharmacies or the NHS app to take a load off GPs. Professor Jason Halford, of the European Association for the Study of Obesity, said: 'These drugs have the potential to help millions. 'If the government and NHS are serious about prevention they need to reconsider their position on the speed of the rollout of these drugs.' Professor John Deanfield, a heart doctor at University College London, added: 'These drugs provide a real opportunity to delay many diseases of ageing all at the same time and potentially transform society. Advertisement 'I hope it won't take 10 years to do something that is so needed.' What if my GP says no? 5 If you are eligible but your GP denies you a prescription, you may be able to ask for a referral to specialist weight management services Credit: Getty MANY people are expected to miss out and some surgeries are already pouring cold water on patients' hopes. Fairhill Medical Practice in Kingston upon Thames said: 'Once we are able to prescribe weight loss injections they will be offered to those with the highest medical need only, which may mean that a lot of patients will be disappointed.' Millions who meet the prescription criteria will simply have to be denied the drugs because doctors are so busy. Advertisement On top of everything else England's 6,300 doctors' surgeries have to deal with, they do not have the capacity to offer the necessary long-term supervision for millions more people at once. Experts reckon private prescriptions will rocket even more as frustrated patients give up waiting. If you are eligible but your GP denies you a prescription, you may be able to ask for a referral to specialist weight management services. Known as tier 2 and tier 3 weight management services, they may prescribe the jabs after other weight loss attempts. Many people are expected to find it easier to go private, with the injections widely available from high street pharmacies like Boots, Superdrug, and even Asda. Advertisement Olivier Picard, of the National Pharmacy Association, said: 'NHS provision won't meet demand straight away, so we fully expect that many people will continue seeking it privately.' Advice for people buying them privately BUYING the drugs online might seem like the faster fix – but buyer beware. Slimming success stories are everywhere but so, too, are tales of horror. Many patients have been duped by dodgy sellers, suffered severe side effects or even died after taking jabs they bought online. Bargain prices, easy tick-box applications, or prescriptions with no follow-up, should all be red flags to online shoppers. Advertisement Many pharmacies have been rapped for giving them away to people who do not meet the obesity criteria, potentially putting their health at risk. Dose strength is partly based on size and pretending you are fatter than you are could mean you end up with a medication too strong for your body, raising the risk of serious side effects. The most common side effects from the injections include feeling sick, vomiting, diarrhoea or other gut troubles. If not treated properly people can suffer more serious impacts like dehydration, gallstones, pancreatitis or allergic reactions – and more than 100 deaths in the UK have so far been linked to the jabs. The General Pharmaceutical Council issued new rules in February to say that all pharmacies must verify a patient's height and weight, and conduct at least a video call – if not face-to-face appointment – before prescribing weight loss injections. Advertisement Dr Emily Pegg, associate vice president at Lilly, which makes Mounjaro, said: 'This is still a prescription-only medicine, should only be prescribed by a registered healthcare professional and needs to be dispensed by a registered pharmacy. 'It is not something that people should be able to buy by just going out and going on to a social media site and clicking a button and it gets delivered to them. 'That is not appropriate and is probably illegal. 'Patient safety is a high priority.' Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. Future of fat jabs WHILE the Mounjaro rollout is expected to kick off with a whimper and not a bang, it is hoped it will mark the beginning of a new era in weight loss medicine. Advertisement Brits have been getting gradually fatter for decades and no medication or government policy has managed to beat the bulge. The drugs appear super-effective, reasonably priced and relatively safe, and could help millions slim down after failed diets. They are expected to reduce the risks of type 2 diabetes, cancer and dementia. And studies increasingly show they improve health in other ways on top of weight loss, too, reducing the risk of heart attacks and strokes. NHS medical director, Professor Sir Stephen Powis, believes they could one day be as transformative as cholesterol-lowering statins, which have slashed heart attacks since they were rolled out decades ago. Advertisement Prof Powis said: 'I think over time it's highly likely that these drugs will become more widespread. 'I think there will be a combination of increased evidence of positive outcomes and costs dropping, and we will learn better how to deploy them. 'This is very exciting – we're in the foothills of learning how to use them.'
Rhyl Journal
a day ago
- Rhyl Journal
Prestatyn grandmother ‘not given medication' for 20 days
Marion Yates, of St Chamond's Care Home, Hillside in Prestatyn, died aged 87 at the nursing home on January 2, 2025. At the resumption of the inquest into her death, held in Ruthin today (June 20), John Gittins, senior coroner for North Wales East and Central, gave a medical cause of death of a chest infection with contributing Alzheimer's and a stroke. Mrs Yates was born in Atherton, Manchester on June 10, 1937, and was widowed, a mother to three sons and a retired business owner. The inquest was told Mrs Yates had been 'very active throughout her life', and was a 'great mum' who had worked for British Coal, in finance, and had run a successful newsagent in Fleetwood twice. Her son told the inquest that she had 'loved baking, loved making clothes, would knit for grandkids and loved home cooking'. She had been diagnosed with Alzheimer's dementia in 2019, but had shown symptoms of the condition since 2016. Mrs Yates moved into residential care, at Priory House Care Home in Prestatyn, in October 2022, and 'seemed really happy' at the home for the first 12 months and enjoyed activities. She had been prescribed edoxaban, an anti-coagulant (blood thinner) which mitigated the risk of a stroke – she had been on thinners for several years. However, in October 2023, while monthly medication had arrived for patients at Priory House on October 18, Mrs Yates' had not. The community pharmacist was contacted and responded that they 'didn't have it yet', said Prio House director Frances Waltham. A daily medication Mrs Yates was now without since October 28, the care home made several requests (both before and after her running out of medication) to the pharmacist for the medication, but by as late as November 16 they had still not received it. A prescription had been sent to the pharmacist on November 16, ten days after the issue was last recorded as being raised. Mrs Yates' GP surgery, Healthy Prestatyn Iach, were not informed at the same time that she had been without medication. Mrs Yates suffered a stroke in December that year, which her family said lead to a 'distinct change and a downward spiral' and her transfer to Ysbyty Glan Clwyd. Dr Gordon Black, a general physician specialising in stroke treatment, said that they had noted Mrs Yates' 'right side weakness, aphasia, and unsafe swallow' in November – between her going without medication and her stroke. She was moved to a community hospital from Glan Clwyd, and then into St Chamond's in Prestatyn in June 2024 having had a paper tube fitted. Her son told the inquest she 'never spoke after that' and 'couldn't move her right side and was bedridden', adding that her 'quality of life completely changed beyond recognition'. READ MORE: 'Loving, caring' Rhuddlan mother will be 'hugely missed' Rhyl: What Dean Mears' life sentence and minimum term mean Dr Judah Eastwell, clinical lead GP at Healthy Prestatyn Iach, said that her receiving her medication when she had been supposed to in October 2023 'would have mitigated risks of stroke'. From November 2024, Mrs Yates had developed a chest infection and was now 'really jaundiced', but Welsh Ambulance Service determined admission to hospital was not necessary. By December, her blood tests showed deterioration of the liver, and an ultrasound scan showed a 'mass', believed to be cancerous, adjacent to the pancreas on her liver. It was decided not to proceed with an investigation into the cancer as this could have caused difficulties with her other health problems. In January, Mrs Yates developed a fever and 'chesty breathing', after which she was given antibiotics and died on January 2. Mr Gittins gave a narrative conclusion, and said: 'For a period of approximately 20 days from 28 October, 2023 due to a prescribing and dispensing error the deceased was not given her medication. 'Her condition deteriorated from the time of the stroke onwards resulting in her being immobile until her death at St Chamond's in Prestatyn. 'Her stroke in 2023 has more than minimally contributed to her death and it is probable that this would not have been the case if medication had been delivered.'
